Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Mantle cell lymphoma outcomes following sequential first-line bendamustine-rituximab and second-line Bruton's tyrosine kinase inhibitor therapy.
Journal: Blood cancer journal
Published: December 12, 2025
IKAROS gain of function disease: Allogeneic hematopoietic cell transplantation experience and expanded clinical phenotypes.
Journal: Clinical immunology (Orlando, Fla.)
Published: October 30, 2023
Impact of early relapse within 24 months after first-line systemic therapy (POD24) on outcomes in patients with marginal zone lymphoma: A US multisite study.
Journal: Journal of hematology & oncology
Published: February 26, 2023
A multicenter analysis of the outcomes with venetoclax in patients with relapsed mantle cell lymphoma.
Journal: Blood advances
Published: September 09, 2022
Postibrutinib relapse outcomes for patients with marginal zone lymphoma.
Journal: Blood advances
Published: July 25, 2022
Predictive factors and outcomes for ibrutinib in relapsed/refractory marginal zone lymphoma: a multicenter cohort study.
Journal: Journal of hematology & oncology
Published: May 30, 2022
Clinical utility of chromosomal microarray in establishing clonality and high risk features in patients with Richter transformation.
Journal: Cancer genetics
Published: March 25, 2021
Last Updated: 09/26/2026